Le Centre Hospitalier du Mans est le principal centre hospitalier de l'agglomération mancelle. Il s'agit de l'un des plus gros centres hospitaliers non-universitaires de France.

During the past decade, CH Le Mans conducted 242 clinical trials. In the 10-year time frame, 242 clinical trials started and 20 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 126 clinical trials started and 13 clinical trials were completed. i.e. 10.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Le Mans" #1 sponsor was "Nantes University Hospital" with 34 trials, followed by "Centre Hospitalier le Mans" with 27 trials sponsored, "University Hospital, Brest" with 19 trials sponsored, "Groupe Francophone des Myelodysplasies" with 17 trials sponsored and "Intergroupe Francophone de Cancerologie Thoracique" with 17 trials sponsored. Other sponsors include 212 different institutions and companies that sponsored additional 107 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Le Mans" #1 collaborator was "Ministry of Health, France" with 8 trials as a collaborator, "Bristol-Myers Squibb" with 7 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Janssen-Cilag Ltd." with 5 trials as a collaborator and "University Hospital, Angers" with 5 trials as a collaborator. Other collaborators include 195 different institutions and companies that were collaborators in the rest 161 trials.

According to Clinical.Site data, the most researched conditions in "CH Le Mans" are "Myelodysplastic Syndromes" (12 trials), "Carcinoma, Non-Small-Cell Lung" (10 trials), "Multiple Myeloma" (10 trials), "Rheumatoid Arthritis" (7 trials) and "Chronic Lymphocytic Leukemia" (6 trials). Many other conditions were trialed in "CH Le Mans" in a lesser frequency.

Most popular intervention types in "CH Le Mans" are "Drug" (176 trials), "Other" (75 trials), "Procedure" (18 trials), "Device" (17 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Pemetrexed" (9 trials), "Rituximab" (8 trials), "Carboplatin" (6 trials) and "Lenalidomide" (6 trials). Other intervention names were less common.

The vast majority of trials in "CH Le Mans" are 313 trials for "All" genders, 13 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "CH Le Mans". 6 are not yet recruiting, 90 are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 148 completed trials in CH Le Mans, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in CH Le Mans, 12 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 105 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 63 trials that are defined as “Not Applicable".

CH Le Mans has several departments that took part in Clinical trials: "Centre Hospitalier - Pneumologie" - 13 trials, "Ch Du Mans; Medecine Hematologie Oncologie" - 7 trials, "CH du Mans - Pavillon Claude Monet" - 2 trials, "Centre Hospitalier Le Mans; Dermatologie" - 2 trials, "Service de cardiologie, CH Le Mans" - 2 trials